ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 92 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $149,812 | -79.3% | 17,856 | -75.4% | 0.00% | -100.0% |
Q1 2023 | $722,179 | +512.0% | 72,727 | +210.8% | 0.00% | -50.0% |
Q2 2022 | $118,000 | +20.4% | 23,400 | -4.3% | 0.00% | +33.3% |
Q1 2022 | $98,000 | -41.0% | 24,457 | -52.2% | 0.00% | -57.1% |
Q4 2021 | $166,000 | -24.2% | 51,216 | +95.9% | 0.01% | +16.7% |
Q3 2021 | $219,000 | -44.8% | 26,141 | -21.8% | 0.01% | -81.8% |
Q1 2021 | $397,000 | – | 33,441 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |